Zhongming Qiu
Clinical trials sponsored by Zhongming Qiu, explained in plain language.
-
New drug ripertamab tested for muscle weakness disease
Disease control Not yet recruitingThis early-stage trial tests whether a single infusion of ripertamab can safely improve daily living activities in 20 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants are randomly assigned to receive the drug or a placebo, and are follo…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for muscle disease: drug trial launches
Disease control Not yet recruitingThis study tests a drug called telitacicept in 30 adults with inflammatory myopathy, a condition where the immune system attacks muscles, causing weakness. The goal is to see if the drug is safe and can control the disease. Participants must have not responded well to standard tr…
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC